Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 GBX | 0.00% | +4.55% | +9.52% |
Apr. 17 | Bivictrix granted FDA orphan drug status for rare cancer treatment | AN |
Apr. 17 | BiVictriX Wins US FDA's Orphan Drug Status for Blood Cancer Treatment | MT |
Business Summary
Number of employees: 17
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tiffany Thorn
FOU | Founder | 37 | 15-12-31 |
Adrian Howd
DFI | Director of Finance/CFO | 52 | 23-10-02 |
Simon Wallwork
SEC | Corporate Secretary | - | 21-06-21 |
Oliver Schon
PRN | Corporate Officer/Principal | - | 21-09-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kauffman
CHM | Chairman | 60 | 22-01-15 |
William Paris
BRD | Director/Board Member | 73 | 21-09-21 |
Susan Lowther
BRD | Director/Board Member | 65 | 21-09-21 |
Tiffany Thorn
FOU | Founder | 37 | 15-12-31 |
Robert Hawkins
BRD | Director/Board Member | 69 | 21-09-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 82,526,088 | 51,083,823 ( 61.90 %) | 0 | 61.90 % |
Company contact information
BiVictriX Therapeutics Plc
Mereside Alderley Park Alderley Edge
SK10 4TG, Macclesfield
+
http://www.bivictrix.comSector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.52% | 12.08M | |
+47.22% | 54.63B | |
-6.56% | 39.92B | |
+37.07% | 38.82B | |
+13.69% | 26.86B | |
-11.17% | 26.22B | |
-21.08% | 18.78B | |
+25.55% | 12.21B | |
+1.00% | 12.16B | |
+26.07% | 11.94B |
- Stock Market
- Equities
- BVX Stock
- Company BiVictriX Therapeutics Plc